| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
33,474,000
|
34,695,000
|
34,726,000
|
34,662,000
| | Cost of Revenue | 30,685,000 | 31,300,000 | 31,312,000 | 31,621,000 | | |
Gross Profit
|
2,789,000
|
3,395,000
|
3,414,000
|
3,041,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 1,298,000 | 1,351,000 | 1,358,000 | 1,294,000 |
|
Non Recurring |
-
| 58,000 | 345,000 |
-
|
|
Others | 430,000 | 402,000 | 402,000 | 386,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,061,000
|
1,584,000
|
1,309,000
|
1,361,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 14,000 | 10,000 | (2,000) | (5,000) |
|
Earnings Before Interest And Taxes | 1,075,000 | 1,594,000 | 1,307,000 | 1,356,000 |
|
Interest Expense | 83,000 | 70,000 | 70,000 | 74,000 |
|
Income Before Tax | 992,000 | 1,524,000 | 1,237,000 | 1,282,000 |
|
Income Tax Expense | 340,000 | 515,000 | 564,000 | 452,000 |
|
Minority Interest | 2,000 | 1,000 | 1,000 | 1,000 |
|
|
|
Net Income From Continuing Ops | 654,000 | 1,009,000 | 673,000 | 830,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
654,000
|
1,010,000
|
674,000
|
831,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
654,000
|
1,010,000
|
674,000
|
831,000
|
|
0.62(1.55%) 9:57AM EDT - Nasdaq Real Time Price